Navigation Links
Study Suggests How Some Cancers Resist Treatment
Date:4/1/2010

Finding shows drug resistance can be lost, treatment can work again

THURSDAY, April 1 (HealthDay News) -- Scientists have identified a mechanism by which certain tumor cells that become resistant to cancer drugs can later lose that resistance.

The discovery may lead to new ways to combat drug resistance in cancer patients, said the authors of the new study, published online April 1 in the journal Cell.

Although the existence of these drug-resistant cells has been common knowledge, scientists "now understand a little bit better how those cells work so they can attack them," said Robert Clarke, a professor of oncology and physiology and biophysics at the Georgetown Lombardi Comprehensive Cancer Center in Washington, D.C.

Study senior author Jeffrey Settleman, scientific director of the Massachusetts General Hospital Cancer Center and professor of medicine at Harvard Medical School, said: "One of the big problems with cancer drug therapy is acquired drug resistance. Most treatments, even ones that work, fail over time because tumors become drug-resistant. It's been largely assumed, and in some cases even demonstrated, that random gene changes confer a lot of that resistance."

But some tumors become susceptible to the cancer drugs after a "drug holiday," indicating that other mechanisms are at play.

"There's a population of cells that's resistant but the resistance is not necessarily maintained forever," Clarke noted.

"This suggests that the resistance is not genetic but could be reversible," added Settleman.

Using models of drug-resistant cells, the study authors found a subpopulation of tumor cells that managed to escape the effects of cancer drugs even when given at levels 100 times greater than those that would kill most cells.

The authors tested a number of different drugs, including gefitinib (Iressa), which is used to treat lung cancer, and lapatinib {Tykerb), used to treat breast cancer. Most of the drugs were provided for free by their manufacturers.

"We always found a small population of cells resistant to treatment and arising at significantly high frequency, [so] we thought it can't be genetic. The numbers just didn't make sense," Settleman said.

But the cells, once removed from the "drugged" environment, gave rise to a new generation of cells that were again susceptible to the drug therapies.

"Cells could randomly acquire and relinquish that drug-tolerance quality at low frequency so that any cell could potentially become drug-tolerant for a period of time, then surrender that ability," Settleman explained. This may be a way for the cells to survive as a group, with individual cells "compromising something for the good of the population," he stated.

An enzyme that changes chromatin, part of the structure of chromosomes, is necessary for a cell to develop tolerance. Although there are no drugs that can inhibit this enzyme, compounds that blocked a group of related enzymes did manage to kill off the drug-resistant cells, the researchers said.

"We discovered that there are inhibitors of certain chromatin-modifying enzymes that can actually selectively kill drug-tolerant cells," Settleman said. "That's where the therapeutic opportunity comes in. We showed that when you combine one of the chromatin-modifying enzyme inhibitors with [a drug] that treats most of the cells, you can wipe out most of the population."

The researchers are now starting a trial to combine an enzyme inhibitor with a lung cancer drug to see if they can prevent the development of resistance.

More information

Learn more about cancer drug resistance at Emory University.



SOURCES: Jeffrey Settleman, Ph.D., scientific director, Massachusetts General Hospital Cancer Center, and professor, medicine, Harvard Medical School, Boston; Robert Clarke, Ph.D., D.Sc., professor, oncology and physiology and of biophysics, Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C.; April 1, 2010, Cell, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Study shows partial lung removal favorable over full removal as treatment for lung cancer
2. New mums beat the blues and increase wellbeing with physio exercise, study reveals
3. Small soda taxes insufficient to curb consumption among children, study finds
4. Study Revives Debate on Prostate Drug
5. Misinformation about antibiotics can travel to large audience via Twitter: study
6. Minority women least likely to gain access to a doctor, study says
7. New national study examines weight training-related injuries
8. Misinformation About Antibiotics Can Travel to Large Audience Via Twitter: Study
9. Radiation after mastectomy underused, U-M study finds
10. Study shows that mutations in 1 gene cause many cancers
11. Age Management Leader Goes Beyond 2010 NANES Study Reqs, Targeting Heightened Obesity Group, Adult 40+
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer ... through a fitness app. The fitness app plans to fix the two major problems leading ... a one size fits all type program , They don’t eliminate all the ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... , June 23, 2016 , ... on Thursday, July 7, 2016 , , , , LOCATION: ... , , , , EXPERT PANELISTS:  , , , ... Senior Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and ... The global pharmaceutical industry is witnessing an exceptional era. ...
Breaking Medicine Technology: